loadpatents
name:-0.0069451332092285
name:-0.0063471794128418
name:-0.00071096420288086
Bien; Jeffrey T. Patent Filings

Bien; Jeffrey T.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bien; Jeffrey T..The latest application filed is for "crystal structures of sglt2 inhibitors and processes for preparing same".

Company Profile
0.7.6
  • Bien; Jeffrey T. - Princeton NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Crystal structures of SGLT2 inhibitors and processes for preparing same
Grant 9,453,039 - Gougoutas , et al. September 27, 2
2016-09-27
Crystal Structures Of Sglt2 Inhibitors And Processes For Preparing Same
App 20130303467 - Gougoutas; Jack Z. ;   et al.
2013-11-14
Crystal structures of SGLT2 inhibitors and processes for preparing same
Grant 8,501,698 - Gougoutas , et al. August 6, 2
2013-08-06
Crystal Structures Of Sglt2 Inhibitors And Processes For Preparing Same
App 20110172176 - Gougoutas; Jack Z. ;   et al.
2011-07-14
Crystal structures of SGLT2 inhibitors and processes for preparing same
Grant 7,919,598 - Gougoutas , et al. April 5, 2
2011-04-05
Method of preparation of azaindole derivatives
Grant 7,820,820 - Liu , et al. October 26, 2
2010-10-26
Method Of Preparation Of Azaindole Derivatives
App 20090312549 - LIU; WANSHENG ;   et al.
2009-12-17
Method of preparation of azaindole derivatives
Grant 7,598,380 - Liu , et al. October 6, 2
2009-10-06
Crystal Structures Of Sglt2 Inhibitors And Processes For Preparing Same
App 20080004336 - Gougoutas; Jack Z. ;   et al.
2008-01-03
Method of preparation of azaindole derivatives
App 20070032503 - Liu; Wansheng ;   et al.
2007-02-08
Process for preparing the antiviral agent [1S-(1alpha,3 alpha,4beta )]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopen- tyl]-6H-purin-6-one
Grant 7,034,152 - Pendri , et al. April 25, 2
2006-04-25
Process for preparing the antiviral agent [1S-(1alpha,3 alpha,4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methyl- enecyclopentyl]-6H-purin-6-one
App 20040192912 - Pendri, Yadagiri R. ;   et al.
2004-09-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed